Daiwa Securities Group
TCRR

Daiwa Securities Group’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Daiwa Securities Group’s Portfolio TCRR Stock Details TCRR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-131
Closed – – 1422
2022
Q3 		$0 Hold
131
– – ﹤0.01% 1429
2022
Q2 		$0 Hold
131
– – ﹤0.01% 1462
2022
Q1 		$0 Hold
131
– – ﹤0.01% 1440
2021
Q4 		$1K Hold
131
– – ﹤0.01% 1375
2021
Q3 		$1K Buy
131
+68
+108% +$961 ﹤0.01% 1298
2021
Q2 		$1K Hold
63
– – ﹤0.01% 1243
2021
Q1 		$1K Hold
63
– – ﹤0.01% 1254
2020
Q4 		$2K Buy
+63
New +$1.59K ﹤0.01% 1148

Other funds holding TCRR

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Daiwa Securities Group's TCRR Position: Q4 2022 in Review

Daiwa Securities Group sold out of TCR2 Therapeutics Inc. Common Stock (TCRR) in Q4 2022, closing a stake of 131 shares.

Daiwa Securities Group first reported a position in TCRR in Q4 2020 and held it in 8 quarters. The position peaked at $2K in Q4 2020. 63 funds tracked by Wall St. Rank hold TCRR as of Q4 2022.

  • Daiwa Securities Group reported no remaining TCR2 Therapeutics Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Daiwa Securities Group sold 131 TCR2 Therapeutics Inc. Common Stock shares in Q4 2022.
  • Daiwa Securities Group first reported a position in TCR2 Therapeutics Inc. Common Stock in Q4 2020 and held it in 8 quarters.
  • Daiwa Securities Group's TCR2 Therapeutics Inc. Common Stock position peaked at $2K in Q4 2020.
  • 63 funds tracked by Wall St. Rank held TCR2 Therapeutics Inc. Common Stock as of Q4 2022.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.